NVO Jan 2025 87.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:55AM EDT. Market open.
| Previous close | 1.3700 |
| Open | 1.3700 |
| Bid | 1.1800 |
| Ask | 1.2800 |
| Strike | 87.50 |
| Expiry date | 2025-01-17 |
| Day's range | 1.3700 - 1.3700 |
| Contract range | N/A |
| Volume | |
| Open interest | 593 |
Yahoo FinanceEli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
Investor's Business DailyBreakouts In Focus: Google Goes Wild As Tasty IPO Sets Up
As Google stock gaps up and gets volatile, Novo Nordisk sets up while a hot IPO and leading chipmaker break out.
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme init
© 2024 Yahoo. All rights reserved.